http://orcid.org/0000-0002-2336-5323
References
- Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. Jama 2009;301(5):489–499. doi: 10.1001/jama.2009.56
- Jakob SM, Ruokonen E, Grounds RM, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. Jama 2012;307(11):1151–1160. doi: 10.1001/jama.2012.304
- Huai J, Ye X. A meta-analysis of critically ill patients reveals several potential risk factors for delirium. Gen Hosp Psychiatry. 2014;36(5):488–496. doi: 10.1016/j.genhosppsych.2014.05.002
- Su X, Meng Z-T, Wu X-H, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet 2016;388(10054):1893–1902. doi: 10.1016/S0140-6736(16)30580-3
- Zhang Z, Pan L, Deng H, et al. Prediction of delirium in critically ill patients with elevated C-reactive protein. J Crit Care. 2014;29(1):88–92. doi: 10.1016/j.jcrc.2013.09.002
- Zhang Y, Wang X, Liu Z, Yu L. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury by targeting NLRP3 via miR-381. J Biochem Mol Toxicol 2018;23:e22211. doi: 10.1002/jbt.22211
- Zhao W, Jia L, Yang H-J, et al. Taurine enhances the protective effect of Dexmedetomidine on sepsis-induced acute lung injury via balancing the immunological system. Biomed Pharmacother. 2018;103:1362–1368. doi: 10.1016/j.biopha.2018.04.150
- Li J, Chen Q, He X, et al. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α2AR/PI3K/Akt pathway. J Transl Med. 2018;16(1):78 doi: 10.1186/s12967-018-1455-1
- Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–620. doi: 10.1016/S2213-2600(14)70097-9
- Zhang Z. Identification of three classes of acute respiratory distress syndrome using latent class analysis. PeerJ. 2018;6:e4592. doi: 10.7717/peerj.4592
- Li J, Dou X, Li D, He M, Han M, Zhang H. Dexmedetomidine ameliorates post-CPB lung injury in rats by activating the PI3K/Akt pathway. J Invest Surg. 2019;33(6):576–583.
- Frenzel J, Gessner C, Sandvoss T, et al. Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry. PLoSONE. 2011;6(10):e25544. doi: 10.1371/journal.pone.0025544
- Umbrello M, Formenti P, Bolgiaghi L, Chiumello D. Current Concepts of ARDS: A Narrative Review. IJMS. 2016;18(1):64. doi: 10.3390/ijms18010064
- Ards Definition Task F, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307(23):2526–2533.
- Alyass A, Turcotte M, Meyre D. From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med Genomics. 2015;8:33. doi: 10.1186/s12920-015-0108-y
- Kawazoe Y, Miyamoto K, Morimoto T, et al. Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis: A Randomized Clinical Trial. Jama 2017;317(13):1321–1328. doi: 10.1001/jama.2017.2088
- Fan E, Brodie D, Slutsky AS. Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment. Jama 2018;319(7):698–710. doi: 10.1001/jama.2017.21907
- Villar J, Ambrós A, Soler JA, et al. Age, PaO2/FIO2, and Plateau Pressure Score: A Proposal for a Simple Outcome Score in Patients With the Acute Respiratory Distress Syndrome. Crit Care Med. 2016;44(7):1361–1369. doi: 10.1097/CCM.0000000000001653
- Merkow JS, Hoerauf JM, Moss AF, et al. Animal experimental research design in critical care. BMC Med Res Methodol. 2018;18(1):71. doi: 10.1186/s12874-018-0526-6